ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Medicamen Biotech Limited held its 33rd Annual General Meeting on September 26, 2026. The meeting concluded after discussing standard business and special resolutions.
Medicamen Biotech Limited filed its notice for the 33rd Annual General Meeting scheduled for September 26, 2026, alongside the Integrated Annual Report for FY 2025-26.
Medicamen Biotech Limited has fixed September 19, 2026, as the record date for its final dividend. The book closure is scheduled from September 20 to September 26, 2026.